Abstract 4949
Background
Despite clear benefits and increased efforts towards earlier integration of palliative care (PC) with oncology, there are concerns that PC remains stigmatized and predominantly associated with end-of-life care (EOLC). This project aims to explore current perceptions and understanding of PC in cancer patients.
Methods
Prospective survey conducted in the oncology ward of a tertiary academic hospital in Melbourne, Australia. Over a 4-month period a 16-item questionnaire was distributed to all cancer patients upon admission to the ward (N = 103). Chi-Squared test was used to examine for significant factors related to patients’ perceptions of PC.
Results
Ninety-six patients (93%) completed the questionnaire; of which 76% had metastatic cancer. Of the domains explored, salient findings were: 1) Familiarity and experience: 76% had heard of PC; while only 21% had received PC. Self-rating of PC knowledge was varied, and evenly distributed: 31% good/excellent, 36% average and 33% below average/poor. 2) Roles of PC and oncology: 86% believed they could receive concurrent oncology care and 81% believed they could receive anti-cancer treatment whilst receiving PC. Those who had heard of PC were significantly more likely to respond that they could receive concurrent anti-cancer treatment (p = 0.005), as well as those who had better self-rated PC knowledge (p = 0.045). 3) Perceptions: 45% believed PC was only associated with EOLC. Those more likely to disagree with this statement had received PC services (p = 0.039). The majority (77%) felt comforted with PC involvement; this was significantly associated with older age (p = 0.047) and an understanding that oncology (p < 0.005) and anti-cancer treatment (p = 0.013) could continue. However, 40% felt frightened and 29% felt hopeless about a referral to PC. Notably, 50% felt more comfortable with “supportive care” services (versus PC), 25% were neutral and 25% were not.
Conclusions
This survey had an excellent response rate and results were reassuring that, in general, respondents had an accurate understanding of and positive perceptions of PC. Familiarity and comfort with PC were associated with significantly better understanding of PC. This may reflect overall progress in integration of PC and oncology care.
Clinical trial identification
Legal entity responsible for the study
Research Support Services, Monash Health.
Funding
Has not received any funding.
Editorial Acknowledgement
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
2595 - Real-Life Utilization of Genomic testing for invasive Breast Cancer patients in Italy and France reduces Chemotherapy Recommendations
Presenter: Sandro Barni
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
2343 - Benefit of adjuvant chemotherapy in hormone receptor-positive, HER2-negative, invasive lobular carcinoma of the breast
Presenter: Alexandre De Nonneville
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
2990 - Baseline lymphocyte counts predict distant recurrence in early breast cancer
Presenter: Gun Min Kim
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
4532 - A propensity score analysis exploring the impact of the addition of adjuvant chemotherapy (aCT) to hormone therapy (aHT) in a multi-center series of resected luminal early stage pure Invasive Lobular Breast Carcinoma (ILC).
Presenter: Luisa Carbognin
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
2344 - Benefit of Adjuvant Systemic Therapies in HR+ HER2- pT1ab Node-Negative Breast Carcinomas
Presenter: Alexandre De Nonneville
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
3525 - Anti-proliferative effect of oral metronomic vinorelbine in PAM50 Luminal/HER2-negative early breast cancer (SOLTI-1501 VENTANA): an open-label, randomized, three-arm, multicenter, window-of-opportunity study
Presenter: Aleix Prat
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
3908 - Clinicopathologic significance of androgen receptor expression and discordant receptor status during progression in breast cancer
Presenter: Chan Heun Park
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
4075 - The outcomes of early breast cancers utilizing the Oncotype Dx Recurrence score (RS) instead of Clinico-pathological (CP) factors for prognostic risk assessment: A Single Institution Experience
Presenter: Adhar Alsayed
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
738 - Circulating tumor cells as a prognostic marker in non metastatic breast cancer patients.
Presenter: Summar Elmorshidy
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract
3151 - Molecular subtyping of breast cancer by dedicated breast PET
Presenter: Satoshi Sueoka
Session: Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care
Resources:
Abstract